136 related articles for article (PubMed ID: 33157430)
1. National trends and determinants of hospitalization for uterine leiomyomas - Portuguese public database analysis from 2000 to 2015.
Gante I; Medeiros-Borges C; Águas F
Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():231-236. PubMed ID: 33157430
[TBL] [Abstract][Full Text] [Related]
2. Hysterectomies in Portugal (2000-2014): What has changed?
Gante I; Medeiros-Borges C; Águas F
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():97-102. PubMed ID: 27914240
[TBL] [Abstract][Full Text] [Related]
3. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
4. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 30-day Complication Rates between Laparoscopic Myomectomy and Total Laparoscopic Hysterectomy for the Treatment of Uterine Leiomyoma in Women Older Than Age 40.
Sheyn D; Bretschnieder CE; Mahajan ST; El-Nashar S; Billow M; Ninivaggio CS
J Minim Invasive Gynecol; 2019; 26(6):1076-1082. PubMed ID: 30385429
[TBL] [Abstract][Full Text] [Related]
6. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
7. Laparoscopic versus abdominal myomectomy: practice patterns and health care use in British Columbia.
Chen I; Lisonkova S; Joseph KS; Williams C; Yong P; Allaire C
J Obstet Gynaecol Can; 2014 Sep; 36(9):817-821. PubMed ID: 25222361
[TBL] [Abstract][Full Text] [Related]
8. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
9. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience.
Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS
J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821
[TBL] [Abstract][Full Text] [Related]
10. The incidence of neoplasm of uncertain behavior of uterus diagnosed after surgery for presumed leiomyoma: A national population-based study.
Yuk JS; Lee JH
Int J Gynaecol Obstet; 2023 Mar; 160(3):1028-1034. PubMed ID: 36149883
[TBL] [Abstract][Full Text] [Related]
11. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
12. [Epidemiological data for uterine fibroids in France in 2010-2012 in medical center--analysis from the French DRG-based information system (PMSI)].
Fernandez H; Chabbert-Buffet N; Koskas M; Nazac A
J Gynecol Obstet Biol Reprod (Paris); 2014 Oct; 43(8):616-28. PubMed ID: 25017711
[TBL] [Abstract][Full Text] [Related]
13. Change in Surgical Practice for Women With Leiomyomas After the U.S. Food and Drug Administration Morcellator Safety Communication.
Clark NM; Schembri M; Jacoby VL
Obstet Gynecol; 2017 Nov; 130(5):1057-1063. PubMed ID: 29016511
[TBL] [Abstract][Full Text] [Related]
14. The impact of anemia on treatment management and clinical outcomes of women hospitalized for uterine leiomyomas.
Antunes D; Gante I; Carvalho MJ; Medeiros-Borges C; Águas F
Ginekol Pol; 2022; 93(10):799-805. PubMed ID: 36196563
[TBL] [Abstract][Full Text] [Related]
15. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures.
Becker ER
J Health Care Finance; 2007; 33(3):1-16. PubMed ID: 19175228
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of undiagnosed uterine leiomyosarcoma in women undergoing hysterectomy or myomectomy for benign indications.
Lange S; Pluchino N; Fehlmann A; Marci R; Boukrid M; Jazia IB; Petignat P; Dubuisson J
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():239-244. PubMed ID: 28743407
[TBL] [Abstract][Full Text] [Related]
17. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review.
Lethaby A; Vollenhoven B; Sowter M
BJOG; 2002 Oct; 109(10):1097-108. PubMed ID: 12387461
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of uterine fibroids in Hesse, Germany, between 1998 and 2004.
Hackethal A; Brüggmann D; Leis A; Langde S; Stillger R; Münstedt K
Fertil Steril; 2009 Mar; 91(3):862-8. PubMed ID: 18304546
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic management of uterine fibroid tumors: updated French guidelines.
Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
